RHYTHM PHARMACEUTICALS, INC. (RYTM)

107.17 -4.76% (-5.36)

Over 5Y: +758.7%

2026-08-28
50 100
2021 2022 2023 2024 2025 2026

Financials Quarterly

Q3 '21 — Revenue: 1M Q3 '21 — Operating Cash Flow: -40.2M Q3 '21 — Free Cash Flow: -40.3M Q3 '21 — Net Income: -35.1M Q4 '21 — Revenue: 1.8M Q4 '21 — Operating Cash Flow: -40.5M Q4 '21 — Free Cash Flow: -40.5M Q4 '21 — Net Income: -42.9M Q1 '22 — Revenue: 1.5M Q1 '22 — Operating Cash Flow: -53.6M Q1 '22 — Free Cash Flow: -53.8M Q1 '22 — Net Income: -52.8M Q2 '22 — Revenue: 9.1M Q2 '22 — Operating Cash Flow: -38.8M Q2 '22 — Free Cash Flow: -38.9M Q2 '22 — Net Income: -45M Q3 '22 — Revenue: 4.3M Q3 '22 — Operating Cash Flow: -47M Q3 '22 — Free Cash Flow: -47.1M Q3 '22 — Net Income: -40.9M Q4 '22 — Revenue: 8.8M Q4 '22 — Operating Cash Flow: -34M Q4 '22 — Free Cash Flow: -34M Q4 '22 — Net Income: -42.5M Q1 '23 — Revenue: 11.5M Q1 '23 — Operating Cash Flow: -36.4M Q1 '23 — Free Cash Flow: -36.5M Q1 '23 — Net Income: -52.2M Q2 '23 — Revenue: 19.2M Q2 '23 — Operating Cash Flow: -41.1M Q2 '23 — Free Cash Flow: -41.1M Q2 '23 — Net Income: -46.7M Q3 '23 — Revenue: 22.5M Q3 '23 — Operating Cash Flow: -29.3M Q3 '23 — Free Cash Flow: -29.3M Q3 '23 — Net Income: -44.2M Q4 '23 — Revenue: 24.2M Q4 '23 — Operating Cash Flow: -29.4M Q4 '23 — Free Cash Flow: -29.4M Q4 '23 — Net Income: -41.6M Q1 '24 — Revenue: 26M Q1 '24 — Operating Cash Flow: -40.7M Q1 '24 — Net Income: -141.4M Q2 '24 — Revenue: 29.1M Q2 '24 — Operating Cash Flow: -29.1M Q2 '24 — Net Income: -32.3M Q3 '24 — Revenue: 33.3M Q3 '24 — Operating Cash Flow: -25.2M Q3 '24 — Net Income: -43.6M Q4 '24 — Revenue: 41.8M Q4 '24 — Operating Cash Flow: -18.8M Q4 '24 — Net Income: -43.3M Q1 '25 — Revenue: 32.7M Q1 '25 — Operating Cash Flow: -40.4M Q1 '25 — Net Income: -49.5M Q2 '25 — Revenue: 48.5M Q2 '25 — Operating Cash Flow: -23.3M Q2 '25 — Net Income: -46.6M Q3 '25 — Revenue: 51.3M Q3 '25 — Operating Cash Flow: -26.6M Q3 '25 — Net Income: -52.9M Q4 '25 — Revenue: 57.3M Q4 '25 — Operating Cash Flow: -25.4M Q4 '25 — Net Income: -47.5M Q1 '26 — Revenue: 60.1M Q1 '26 — Operating Cash Flow: -44.2M Q1 '26 — Net Income: -55.6M Q2 '26 — Revenue: 71.3M Q2 '26 — Operating Cash Flow: -9.2M Q2 '26 — Net Income: -49.3M -100M -50M 0 50M 100M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.6
SBC / sales 36.4%
OE margin -80.7%
Oper. margin -83.6%
Accruals -22.9%
Gross margin 89.0%
EBITDA margin -83.4%
FCF margin -44.3%
OCF margin -43.9%
Profit margin -85.6%
ROA -47.0%
ROCE -64.0%
ROE -199.4%
OCF / EBIT —
ROIC —

4 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

5.0
RPO / sales —
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.5
ND/EBITDA —
Interest cover -10.9×
Cash / Debt 3.1×
Debt payback 0.0 yr
Quick ratio 3.2×
Cash runway 2.1 yr
F-score 6.0 pts
Debt / Eq 1.0×
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

7.4
Sales CAGR 4Y +178.5%
Sales/sh Y/Y +44.1%
Sales Q/Q +46.9%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.